Medical News Today: Study finds drug improves survival for patients with non-small cell lung cancer
A new phase 3 trial finds that overall survival is longer for patient with non-small cell lung cancer treated with the drug nivolumab compared with chemotherapy drug docetaxel.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Lung Cancer Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Health | Lung Cancer | Non-Small Cell Lung Cancer | Study | Taxotere